PT - JOURNAL ARTICLE AU - Zou, Zhuoru AU - Fairley, Christopher K AU - Shen, Mingwang AU - Scott, Nick AU - Xu, Xianglong AU - Li, Zengbing AU - Li, Rui AU - Zhuang, Guihua AU - Zhang, Lei TI - Critical timing for triggering public health interventions to prevent COVID-19 resurgence: a mathematical modelling study AID - 10.1101/2021.07.06.21260055 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.06.21260055 4099 - http://medrxiv.org/content/early/2021/07/07/2021.07.06.21260055.short 4100 - http://medrxiv.org/content/early/2021/07/07/2021.07.06.21260055.full AB - To prevent the catastrophic health and economic consequences from COVID-19 epidemics, some nations have aimed for no community transmission outside of quarantine. To achieve this, governments have had to respond rapidly to outbreaks with public health interventions. But the exact characteristics of an outbreak that trigger these measures differ and are poorly defined. We used existing data from epidemics in Australia to establish a practical model to assist stakeholders in making decisions about the optimal timing and extent of interventions. We found that the number of reported cases on the day that interventions commenced strongly predicted the size of the outbreaks. We quantified how effective interventions were at containing outbreaks in relation to the number of cases at the time the interventions commenced. We also found that containing epidemics from novel variants that had higher transmissibility would require more stringent interventions that commenced earlier. In contrast, increasing vaccination coverage would enable more relaxed interventions. Our model highlights the importance of early and decisive action in the early phase of an outbreak if governments aimed for zero community transmission, although new variants and vaccination coverage may change this.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Xi'an Jiaotong University Health Science CentreAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that supports the findings of this study are available in the supplementary material of this article.